Molbio Diagnostics
-
Molbio Diagnostics raises $85 M from Temasek
Molbio will utilise the funds to expand its global network Singapore-based investment firm Temasek has invested $85 million (around Rs…
Read More » -
Molbio Diagnostics’ iNTP to accelerate TB diagnosis
iNTP is a collaboration between Stop TB Partnership, USAID and UNOPS in nine high TB burden countries in Asia and…
Read More » -
Molbio Diagnostics launches Truenat RT-PCR Test for HIV 1/ HIV 2
Truenat HIV1/HIV 2 will detect and quantitatively diagnose HIV types 1 and 2 with a sample-to-result time of one hour…
Read More » -
Molecular testing is expected to become more of a routine clinical diagnostics
Primary healthcare needs to be strengthened and upgraded substantially to ensure early and timely interventions. By Sriram Natarajan, CEO, Founder…
Read More » -
Molbio launches Truenat Scrub T test for Scrub Typhus
A chip-based, multi-disease platform can test over 30 diseases Molbio Diagnostics, the innovator of Truenat, a point of care Real-Time…
Read More » -
MolBio aims to be the solution in global covid testing
Sriram Natarajan, CEO, Founder & Director, Molbio Diagnostics explains how the company’s innovative technology could offer POC COVID testing The…
Read More » -
Truenat test kit gets DCGI approval for Nipah diagnosis
This is the first kit in India to receive regulatory approval to conduct tests for Nipah Truenat, an innovative point…
Read More »